A Case Series Comparing T+LRTI to Partial Trapeziectomy for Thumb Osteoarthritis

March 12, 2024 updated by: McMaster University

Measuring the Quality of Life in Patients Receiving a Partial Trapeziectomy (PT) Using a "Minimalist Approach" Versus a Complete Trapeziectomy With Ligament Reconstruction and Tendon Interposition (T+LRTI)

The purpose of this study was to measure the differences in Health Related Quality of Life (HRQOL) and functional measurements between two groups of patients with Carpometacarpal Osteoarthritis of the thumb.

Study Overview

Detailed Description

Two patient groups, who have been diagnosed with Carpometacarpal Osteoarthritis of the thumb were compared to measure the Health Related Quality of life (HRQOL) and functional outcomes following two different surgical procedures. The first procedure is currently the most used procedure is North America, Trapeziectomy with Ligament Reconstruction and Tendon Interposition (T+LRTI); this procedure is compared to Partial Trapeziectomy and Tendon Interposition (PT+TI). HRQOL is measured using three questionnaires: one generic, one condition specific and one to measure utility (costs). Patients received their procedures from the respective surgeons and then came in for regular follow up at 1, 3, 6 and 12 months. At these follow up visits the questionnaires and functional measurements (including grip, key pinch and tip pinch strength), were completed

Study Type

Observational

Enrollment (Actual)

20

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adults (Over the age of 18) who have been diagnosed with CMCJ OA of the thumb, Eaton stages II-IV who are english speaking with no other existing hand pathology.

Description

Inclusion Criteria:

  • Diagnosis of advanced stage (Eaton stages II-IV) Carpometacarpal joint (CMCJ) osteoarthritis (OA of the thumb
  • Willingness to undergo surgery for CMCJ OA;
  • Over the age of 18;
  • Able to provide informed consent; and
  • Ability to read and comprehend English to complete the HRQOL questionnaires

Exclusion Criteria:

  • 1) Diagnosis of Eaton stage I CMCJ OA of the thumb [17]; 2) Under the age of 18; 3) Presence of any concomitant hand pathology (including rheumatoid arthritis, neuropathy and traumatic arthritis); and 4) Previous surgery on the same hand or currently under consideration for other unrelated hand surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
T+LRTI Patients
Patients who received Trapeziectomy with Ligament Reconstruction and Tendon Interposition.
T+LRTI is the most commonly used procedure, it removes the entire trapezium
PT+TI Patients
Patients who received the Partial Trapeziectomy and Tendon Interposition
The PT+TI is less invasive than the T+LRTI as only part of the trapezium is removed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Health Related Quality of Life (HRQOL) as measured by the Short Form 36v2 (SF-36)
Time Frame: 1 week pre-operatively plus 1, 3, 6 and 12 month post-operatively
The Short-Form 36v2 [SF-36] is a Generic HRQOL questionnaire
1 week pre-operatively plus 1, 3, 6 and 12 month post-operatively
Change in Health Related Quality of Life (HRQOL) as measured by the Disabilities of the Arm, Shoulder and Hand (DASH)
Time Frame: 1 week pre-operatively plus 1, 3, 6 and 12 month post-operatively
The DASH is a condition specific questionnaire
1 week pre-operatively plus 1, 3, 6 and 12 month post-operatively
Change in HRQOL as measured by The EuroQol-5D-3L [EQ-5D]
Time Frame: 1 week pre-operatively plus 1, 3, 6 and 12 month post-operatively
The EQ-5D is a questionnaire that allows utility to be calculated
1 week pre-operatively plus 1, 3, 6 and 12 month post-operatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in functional performance as measured by Grip Strength
Time Frame: 1 week pre-operatively and 3, 6 and 12 month post-operatively
Force applied by the hand, measured by a goniometer in kilograms
1 week pre-operatively and 3, 6 and 12 month post-operatively
Change in functional performance as measured by Two-Point Pinch Strength
Time Frame: 1 week pre-operatively and 1, 3, 6 and 12 month post-operatively
Force applied by the tip of the thumb and the tip of the index finger, measured by a goniometer in kilograms
1 week pre-operatively and 1, 3, 6 and 12 month post-operatively
Change in functional performance as measured by Key Pinch Strength
Time Frame: 1 week pre-operatively and 3, 6 and 12 month post-operatively
Force applied by the pad of the thumb and lateral surface of the index finger, measured by a goniometer in kilograms
1 week pre-operatively and 3, 6 and 12 month post-operatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Achilles Thoma, MD, McMaster University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2012

Primary Completion (Actual)

November 30, 2015

Study Completion (Actual)

November 30, 2015

Study Registration Dates

First Submitted

December 6, 2017

First Submitted That Met QC Criteria

January 2, 2018

First Posted (Actual)

January 8, 2018

Study Record Updates

Last Update Posted (Actual)

March 13, 2024

Last Update Submitted That Met QC Criteria

March 12, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

the data will not be made to other researchers, the final results will be anonymized and hopefully published in scientific journals

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthritis

Clinical Trials on T+LRTI

3
Subscribe